Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors, 2014---port. (Hagop M. Kantarjian)
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia, cop. 2012---port. (Hagop Kantarjian, Farhad Ravandi, Susan O'Brien... [et al.])
WWW LC Auth., 12-1-2017---(Kantarjian, Hagop; 1952-)
|